Quantum Pharma looks to meet FY market expectations

Quantum Pharma has made good progress during its first half, in line with management views, and anticipates meeting market expectations for the full year.

"As previously indicated, the group's performance for the year is second-half weighted and will be dependent on the level of sales achieved by recent product launches," it said.

The company added that its performance was further linked to the timing and sales of further product launches due to be delivered in the remainder of the year.

At about 11:50 BST, shares in Quantum were down 7.18% to 80.75p.